Citations

Showing 10 of 108162 citations.

P1‐330: THE RELATION BETWEEN MRI FINDINGS AND COGNITIVE IMPAIRMENT IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS AND THE MODIFYING EFFECT OF ALBUMINURIA
Murray, Anne M. , Burns, Christine , Davey, Cynthia , Tupper, David E., Wille, Samantha, Steinert, Kaely, Vemuri, Prashanthi , Lundt, Emily S. , Jack, Clifford R. , Knopman, David S.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2019.06.885 Get It

P1‐311: DEVELOPMENT OF AN INTERNATIONAL POSTERIOR CORTICAL ATROPHY BIOREGISTRY
Pelak, Victoria S. , Tang‐Wai, David F. , Onyike, Chiadi U. , Olds, Jennifer, Hills, William L., Bretsch, Candace, Lusk, Jerri, Boyd, Timothy, Pressman, Peter , Holden, Samantha K. , Bettcher, Bri M., Bouwman, Femke H. , Murray, Melissa E. , Day, Gregory S. , Migliaccio, Raffaella Lara , Potter, Huntington , Boyd, Timothy D.

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2019.06.866 Get It

P1‐148: ALPHA‐SYNUCLEIN PHOSPHORYLATION BY HOMOCYSTEINE
Enomoto, Soichi, Jiang, Peizhou , Shirafuji, Norimichi, Sasaki, Hirohito, Yamaguchi, Tomohisa, Ueno, Asako , Yamamura, Osamu , Nakamoto, Yasunari , Hamano, Tadanori , Ikawa, Masamichi

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_5 | Pages: No page available

10.1016/j.jalz.2019.06.703 Get It

Editorial: accelerated infliximab induction—it’s time to settle the debate!
Chedid, Victor , Kane, Sunanda V. , Chedid, Victor G

Mayo Clinic

Alimentary Pharmacology & Therapeutics | October 18, 2019 | Volume: 50 | Issue: 9 | Pages: 1060-1061

10.1111/apt.15483 | PMID 31625192 Get It

LINKED CONTENTThis article is linked to Sebastian et al papers. To view these articles, visit https://doi.org/10.1111/apt.15456 and https://doi.org/10.1111/apt.15498.
Unfractionated heparin infusion for treatment of venous thromboembolism based on actual body weight without dose capping
Shlensky, Julia A , Thurber, Kristina M., O’Meara, John G. , Ou, Narith N., Osborn, Jennifer L., Dierkhising, Ross , Mara, Kristin C. , Bierle, Dennis M. , Daniels, Paul R. , Dierkhising, Ross A, Mara, Kristin C , Osborn, Jennifer L

Mayo Clinic

Vascular Medicine | October 18, 2019 | Volume: 25 | Issue: 1 | Pages: 47-54

10.1177/1358863x19875813 | PMID 31623539 Get It

Controversy exists regarding the use of dose capping of weight-based unfractionated heparin (UFH) infusions in obese and morbidly obese patients. The primary objective of this study was to compare time to first therapeutic activated partial thromboplastin time (aPTT) in hospitalized patients receiving UFH for acute venous thromboembolism (VTE) among three body mass index (BMI) cohorts: non-obese (< 30 kg/m 2 ), obese (30–39.9 kg/m 2 ), and morbidly obese (⩾ 40 kg/m 2 ). In this single-center, retrospective cohort study, patients were included if they ⩾ 18 years of age, had a documented VTE, and were on an infusion of UFH for at least 24 hours. Weight-based UFH doses were calculated using actual body weight. A total of 423 patients met the inclusion criteria, with 230 (54.4%), 146 (34.5%), and 47 (11.1%) patients in the non-obese, obese, and morbidly obese cohorts, respectively. Median times to therapeutic aPTT were 16.4, 16.6, and 17.1 hours in each cohort. Within 24 hours, the cumulative incidence rates for therapeutic aPTT were 70.7% for the non-obese group, 69.9% for the obese group, and 61.7% for the morbidly obese group (obese vs non-obese: HR = 1.02, 95% CI: 0.82–1.26, p = 0.88; morbidly obese vs non-obese: HR = 0.87, 95% CI: 0.62–1.21, p = 0.41). There was no significant difference in major bleeding events between BMI groups (obese vs non-obese, p = 0.91; morbidly obese vs non-obese, p = 0.98). Based on our study, heparin dosing based on actual body weight without a dose cap is safe and effective.
Stellate ganglion block and cardiac sympathetic denervation in patients with inappropriate sinus tachycardia
Cha, Yong‐Mei , Li, Xuping , Yang, Mei , Han, Jie , Wu, Gang , Noseworthy, Peter A. , Mulpuru, Siva K. , Asirvatham, Samuel J. , Brady, Peter A. , Rho, Richard H., Friedman, Paul A. , Lee, Hon‐Chi, Tian, Ying , Zhou, Shenghua , Munger, Thomas M. , Ackerman, Michael J. , Shen, Win‐Kuang , Kapa, Suraj , Noseworthy, Peter A , Mulpuru, Siva K , Asirvatham, Samuel J , Friedman, Paul A , Zhou, Shenghua , Kapa, Suraj , McLeod, Christopher J. , Zhou, Shenghua

Mayo Clinic

Journal of Cardiovascular Electrophysiology | October 18, 2019 | Volume: 30 | Issue: 12 | Pages: 2920-2928

10.1111/jce.14233 | PMID 31625219 Get It

AbstractBackgroundInappropriate sinus tachycardia (IST) remains a clinical challenge because patients often are highly symptomatic and not responsive to medical therapy.ObjectiveTo study the safety and efficacy of stellate ganglion (SG) block and cardiac sympathetic denervation (CSD) in patients with IST.MethodsTwelve consecutive patients who had drug‐refractory IST (10 women) were studied. According to a prospectively initiated protocol, five patients underwent an electrophysiologic study before and after SG block (electrophysiology study group). The subsequent seven patients had ambulatory Holter monitoring before and after SG block (ambulatory group). All patients underwent SG block on the right side first, and then on the left side. Selected patients who had heart rate reduction ≥15 beats per minute (bpm) were recommended to consider CSD.ResultsThe mean (SD) baseline heart rate (HR) was 106 (21) bpm. The HR significantly decreased to 93 (20) bpm (P = .02) at 10 minutes after right SG block and remained significantly slower at 97(19) bpm at 60 minutes. Left SG block reduced HR from 99 (21) to 87(16) bpm (P = .02) at 60 minutes. SG block had no significant effect on blood pressure or HR response to isoproterenol or exercise (all P > .05). Five patients underwent right (n = 4) or bilateral (n = 1) CSD. The clinical outcomes were heterogeneous: one patient had complete and two had partial symptomatic relief, and two did not have improvement.ConclusionSG blockade modestly reduces resting HR but has no significant effect on HR during exercise. Permanent CSD may have a modest role in alleviating symptoms in selected patients with IST.
Inpatient Outcomes in Dialysis Dependent Patients Undergoing Elective Cervical Spine Surgery for Degenerative Cervical Conditions
Mitchell, Sean M. , White, Anthony M. , Campbell, David H. , Chutkan, Norman , Chung, Andrew, White, Anthony M. , Chung, Andrew S.

Mayo Clinic

Global Spine Journal | October 18, 2019 | Volume: 10 | Issue: 7 | Pages: 856-862

10.1177/2192568219883257 | PMID 32905731 Get It

Study Design: Retrospective cohort study. Objective: To evaluate inpatient outcomes in dialysis dependent patients undergoing elective cervical spine surgery. Methods: A total of 1605 dialysis dependent patients undergoing elective primary or revision cervical spine surgery for degenerative conditions were identified from the National Inpatient sample from 2002 to 2012 and compared to 1 450 642 nondialysis-dependent patients undergoing the same procedures. The National Inpatient Sample is a de-identified database; thus, no institutional review board approval was needed. Results: Dialysis dependence was associated with higher inpatient mortality rates (7.5% vs 1.9%; P < .001) as well as both major (17.3% vs 0.6%; P < .001) and minor (36.8% vs 10.5%; P < .001) complication rates as compared with nondialysis-dependent patients. Dialysis-dependent patients had substantially increased mean lengths of stay (9.8 days compared with 2.0 days; P < .001) and total hospital charges ($141 790 compared with $46 562; P < .001). Conclusion: Dialysis-dependence is associated with drastically increased complication rates, risk of mortality, and represent a significant financial and psychosocial burden to patients undergoing elective cervical spine surgery. Both surgeons and patients should be aware of these risks while planning elective surgeries.
Response to Letter to the Editor: “Pheochromocytoma Characteristics and Behavior Differ Depending on Method of Discovery”
Gruber, Lucinda , Young, William F. , Bancos, Irina

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 17, 2019 | Volume: 105 | Issue: 2 | Pages: 569-570

10.1210/clinem/dgz084 | PMID 31624835 Get It

Latest Trends in Subpectoral Breast Reconstruction
Oh, Christine , Winocour, Sebastian, Lemaine, Valérie

Mayo Clinic

Seminars in Plastic Surgery | October 17, 2019 | Volume: 33 | Issue: 04 | Pages: 224-228

10.1055/s-0039-1696964 | PMID 31632204 Get It

AbstractThere has been a shift in recent years toward a growing popularity of implant-based breast reconstruction, especially in the setting of increased frequency of concurrent contralateral prophylactic mastectomy. Advancements in implant safety and technology have also allowed for an expanding implant reconstruction practice across the country. The traditional approach is immediate two-stage implant reconstruction with placement of a tissue expander within a subpectoral pocket. The introduction of acellular dermal matrix has revolutionized implant-based breast reconstruction, allowing surgeons the opportunity to minimize morbidity while maximizing aesthetic outcomes. There have also been advances in the management of postoperative pain control as well as secondary revision surgery.